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Background: The Lower Limb Functional Index (LLFI) is a relatively recently published regional outcome measure.
The development article showed the LLFI had robust and valid clinimetric properties with sound psychometric and
practical characteristics when compared to the Lower Limb Extremity Scale (LEFS) criterion standard.
Objective: The purpose of this study was cross cultural adaptation and validation of the LLFI Spanish-version
(LLFI-Sp) in a Spanish population.
Methods: A two stage observational study was conducted. The LLFI was initially cross-culturally adapted to Spanish
through double forward and single backward translation; then subsequently validated for the psychometric
characteristics of validity, internal consistency, reliability, error score and factor structure. Participants (n = 136)
with various lower limb conditions of >12 weeks duration completed the LLFI-Sp, Western Ontario and McMaster
University Osteoarthritis Index (WOMAC) and the Euroqol Health Questionnaire 5 Dimensions (EQ-5D-3 L). The full sample
was employed to determine internal consistency, concurrent criterion validity, construct validity and factor structure; a
subgroup (n = 45) determined reliability at seven days concurrently completing a global rating of change scale.
Results: The LLFI-Sp demonstrated high but not excessive internal consistency (α = 0.91) and high reliability (ICC = 0.96).
The factor structure was one-dimensional which supported the construct validity. Criterion validity with the WOMAC was
strong (r = 0.77) and with the EQ-5D-3 L fair and inversely correlated (r = −0.62). The study limitations included the lack of
longitudinal data and the determination of responsiveness.
Conclusions: The LLFI-Sp supports the findings of the original English version as being a valid lower limb regional
outcome measure. It demonstrated similar psychometric properties for internal consistency, validity, reliability, error
score and factor structure.
Keywords: Lower limb, Psychometrics, Outcome assessment, SpanishIntroduction
Patient reported outcome (PRO) measures [1,2] are an
integral part and process of the management of a pa-
tient’s health. These tools are primarily used to object-
ively determine any response or change in a patient’s
status as a consequence of natural healing or the use
of an intervention [3]. In this way there is a rapid* Correspondence: acuesta.var@gmail.com
1Departamento de Psiquiatría y Fisioterapia, Facultad de Ciencias de la Salud,
Universidad de Malaga, Andalucia Tech, Instituto de Biomedicina de Malaga
(IBIMA), Grupo de Clinimetria (AE-14), Málaga, Spain
2School of Clinical Science, Faculty of Health at the Queensland University of
Technology, Brisbane, Australia
Full list of author information is available at the end of the article
© 2014 Cuesta-Vargas et al.; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.assimilation and understanding by the clinicians’ and re-
searchers’ of how function and symptoms have changed
in response to an intervention on a condition or disease
and what effect this has had on the patient’s capabilities
[4]. The progression of this patient focused model has
seen a gradual shift over the last two decades away from
condition or disease specific measures and towards re-
gion specific PROs [5,6]. These regional tools reflect a
change in status in the three key kinetic-chain regions of
the upper and lower [7,8] limbs and the spine [9].
For the kinetic-region of the lower limb, various in-
struments have been designed to measure and evaluate
symptomatology as a single kinetic chain [7,10-15] whileentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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for the hip and knee [16-20]. Both regional and condi-
tion specific tools are not only used to indicate the ef-
fectiveness of an intervention but can also assist in
guiding the decision process on what treatments to con-
tinue, adopt or change. They also assist in the determin-
ation of pre- and post-operative comparison of status
and subsequent monitoring of the patient and their re-
covery during rehabilitation [7]. Generic health related
questionnaires such as the Euroqol Health Questionnaire
5 Dimensions (EQ-5D-3 L) mix a wide range of quality-
of-life dimensions and include a sixth question on over-
all perceived health-related status. These scales may not
provide a complete picture of a particular functional
component. Instead the questionnaire’s constructs aim to
measure the patient’s overall health status and conse-
quently can serve as a criterion-related validity indicator of
general health.
Numerous lower-limb patient reported outcome mea-
sures assess function for specific joints [21-25], joint
conditions [26-29], or region-specific conditions [30-33].
However, there is limited consensus regarding which
tools to use [7,16]. The most commonly advocated and
employed lower limb PROs are the regional Lower
Extremity Functional Scale (LEFS) [10] and the disease-
specific Western Ontario and McMaster Universities
(WOMAC) questionnaire [20,34].
Both tools are widely used with translations into sev-
eral languages. For the LEFS this includes Portuguese,
Persian and Dutch, however no validated Spanish ver-
sion is available. For the WOMAC, a Spanish translated
version has been adapted [17] and validated in a chronic
population [20]. Despite being developed as a disease
specific PRO and shown to have lower clinimetric cap-
acity than the LEFS [34], the WOMAC has served as a
regional PRO [34-36]. The WOMAC has multiple trans-
lations and by consequence, though not ideal, it is cur-
rently the only potentially applicable lower limb regional
criterion PRO tool that is validated and available in
Spanish [19,20,34] where the psychometric properties
were compared to the LEFS [37].
The Lower Limb Functional Index (LLFI) is another
recent example of a lower limb regional PRO. The LLFI
was published in 2012 and accepted by various profes-
sional and governmental organisations [7] as well as in-
dependent outcome assessment agencies [38]. The LLFI
was developed in line with the WHO-ICF [39] and used
a combination of constructs that included body func-
tions, body structures, activities and participation and
environmental factors. The LLFI was shown to have
strong clinimetric properties [6] that were preferable to
those of the LEFS [7]. These properties included the psy-
chometric characteristics of reliability, validity, respon-
siveness, error measurement and internal consistency.From the practical characteristics perspective [7] it
showed brevity, ready transferability to a 100-point scale,
ease and rapidity of completion and scoring, low missing
responses and suitable readability. The LLFI was also
shown [7] to have a single factor structure [36]. In view
of the findings of preferable clinimetric properties for this
lower limb PRO [7], translation to a Spanish version was
warranted. This was supported by findings that compar-
able PROs in the functional index series for the upper
limb [40] and spine [9] were found to be preferable to
other advocated English criterion PROs within their de-
velopment studies and in independent research including
translated versions in French and Spanish [41].
A Spanish version of the LLFI had not been adapted
and validated to date. This is significant given that
Spanish is one of the five most spoken languages and the
second widest geographically spoken [42]. Consequently a
Spanish version, the LLFI-Sp, was developed to meet this
need. Therefore the aims of this paper were: to describe
the process of translation and cross-cultural adaptation of
the original LLFI to Spanish; and to subsequently assess
the five critical psychometric properties of reliability, one-
dimensional factor structure, internal consistency, meas-
urement error and concurrent criterion validity for clinical
use with Spanish speakers. The hypothesis of the present
study is that new LLFI-Sp must show a strong relationship
with WOMAC as the region specific criterion.
Materials and methods
Design
This was a two stage observational study. Stage 1 in-
volved the initial Spanish translation and cross-cultural
adaptation of the LLFI [7]. Stage 2 involved a prospect-
ive evaluation of the LLFI-Sp’s critical psychometric
properties. This included the concurrent completion, in
a Spanish physical therapy outpatients’ population, of
the LLFI-Sp with a lower limb regional criterion, the
WOMAC [19], and a general health questionnaire, the
EQ-5D-3 L [43]. The WOMAC provided a criterion spe-
cific comparison for the lower limb while the EQ-5D-
3 L enabled a clarification and criterion standard for
comparison of the participants’ health status. Two asses-
sors performed the initial and subsequent assessment of
data obtained from the questionnaires that were all com-
pleted independently by the participants. The assessors
were blinded to baseline scores in order to ensure inde-
pendent collection of outcome data.
Stage 1 - Translation of the LLFI to the “LLFI-Sp”
The primary objective of this aspect of the study was to
ensure that the conceptual equivalence of the used terms
was retained in a culturally Spanish-specific translation.
A direct and reverse translation methodology was ap-
plied that involved two native English speakers for the
Table 1 Demographic characteristics and frequency of
diagnosis of the study population
Characteristic Cases (%) Age (years) Mean (sd)
Study population 136 48 ± 19
Male 62 (45.6%) 50 ± 20
Female 74 (54.4%) 46 ± 25
Subregion
Hip 34 56 ± 19
- Bursa 23
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reverse translation. All were specialists in their field,
as detailed and recommended in the specialized scien-
tific literature (Figure 1) [44], and as performed in the
cross-cultural adaptation to Spanish of other PRO
tools [41]. The documents from Translators 1 and 2
showed minimally discernible differences that enabled
the final consensus document to be rapidly achieved
through a consensus approach of a unanimous agreement
on the final version of each item between all translators
(Figure 1).
Stage 2 - Prospective Psychometric Investigation
Participants, setting and procedure
A total of 136 consecutive volunteers (48 ± 19 years,
54.4% female) with a variety of chronic (>12 weeks dur-
ation) lower limb conditions were recruited from the
Physical Therapy Outpatients Clinic at the Malaga Uni-
versity in Spain prior to treatment commencement. The
criteria for inclusion were a lower limb injury and diag-
nosis by a medical practitioner. The chronic status was
determined as >12 weeks duration [45] and that any
acute treatment had been finalized when the participant
was recruited. The chronic status was required as the
WOMAC Spanish version had only been validated in
chronic patients [20]. This also provided the additional
validation of the LLFI in a chronic population as theFigure 1 Flowchart of the translation of the Lower Limb
Functional Index (LLFI) from English to Spanish.original study involved an acute population. The pre-
senting conditions and diagnoses were broadly classified
into six regional sub-categories (Table 1). The exclusion
criteria were age <18 years and poor Spanish language
comprehension as required for the completion of the
questionnaires and assessed subjectively by the therapist
in conjunction with the participant’s feedback on com-
prehension ability. All participants with eligible criteria
completed all three Spanish language self-administered
questionnaires, the LLFI-Sp, WOMAC and the EQ-5D-
3 L, independently at baseline. Those involved in the re-
liability study provided a repeat score at day seven and
completion of a 5-point global rating of change scale
[46]. This study was conducted in accordance with the
ethical principles for medical research involving human- Capsule 3
- Impingement 5
- Other 3
Thigh 8 38 ± 21
- Muscle strain 7
- Haematoma 1
Knee 58 50 ± 19
- Ligament (MCL, LCL, ACL) 33
- PFJ 22
- Other 3
Calf and Shin 9 32 ± 23
- Muscle strain 7
- Haematoma 2
Ankle 12 46 ± 19
- Ligament 10
- Other 2
Foot 6 50 ± 21
- Joint 4
- Other 2
Other 9 59 ± 21
- Whole leg, 6
- Ulcers, 1
- Other 2
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committee of the University of Malaga, (Spain).
The LLFI is a 25-item regional PRO with 3-point
response options of ‘Yes’ (points = 1), ‘Partly’ or ‘Half ’
(points = 1/2) and No’ (points = 0) with a raw score
range of 0 to 25 points. It requires approximately two
minutes to be completed. The score is calculated by sim-
ple addition of the responses then multiplied by four for
conversion to a percentage scale or maximal loss of
function. The total score subtracted from 100 gives a
functional score as a percentage of pre-injury or normal
status [7].
The WOMAC is a 24-item disease-specific ques-
tionnaire developed for patients with hip or knee
osteoarthritis (OA). It requires approximately five mi-
nutes to be completed. It is a multidimensional scale
grouped into three dimensions: pain (five items), stiff-
ness (two items) and physical function (17 items). The
version with five response levels for each item was
used, scored from 0 to 4, which represented different
degrees of intensity. The final score in the Spanish
version was validated as determined by adding the ag-
gregate of the three dimensions scores [19,20]. The
higher the score the worse the patient’s condition with
improvement indicated by an overall score reduction
[19,20]. The data were standardized to a 100 percent
scale where 0 represented optimal health and 100 the
worst possible status. The original and Spanish ques-
tionnaires are both previously determined to be reli-
able, valid and sensitive to the changes in the health
status of patients with hip or knee OA [18-20].
The EQ-5D-3 L is a widely used six-item non-disease-
specific questionnaire. It has five 3-point response op-
tions for different quality-of-life dimensions and a sixth
question on overall perceived health-related status Visual
Analogue Scale (VAS). The EQ-5D-3 L-VAS is used
to reflect the respondent’s self-rated health status on
a 100 mm scale and ranked from ‘Best Imaginable’
(100) to Worst Imaginable’ (0). The EQ-5D-3 L has
been demonstrated as valid and reliable in the Spanish
population [42].
Reliability was performed using the Intraclass Correl-
ation Coefficient Type 2,1 (ICC2.1) test-retest method-
ology in a randomly selected subgroup of the full
sample. Randomization was performed by a computer
generated list of numbers that was used against the
patient participant number with no refusal or drop outs
within in this reliability subgroup (n = 45, 49 ± 3 years,
56.1% female). Their presenting conditions were verified
as representative of the six area sub-categories of the full
sample. The LLFI-Sp baseline and the repeated measures,
taken at seven days [47] following a period during which
there was no treatment, were both expressed with a 95%
CI. To clarify that no change in status had occurredbetween the two measurement intervals a 5- point global
rating of change was employed with a limitation of one
scale point difference [46].
Statistics
Descriptive analyses were applied to calculate means
and standard deviations of the demographic variables
(Table 1). Distribution and normality were determined
by the one-sample Kolmogorov-Smirnov tests. Construct
validity was determined through the use of factor struc-
ture where a single factor structure would indicate that
all items were reflective of the construct of interest –
lower limb functional status. Both construct validity and
factor structure were determined from maximum likeli-
hood extraction (MLE) with the a-priori extraction
requirements being satisfaction of three critera: screeplot
inflection, Eigenvalue >1.0 and variance >10%. We satisfied
the recommended minimum ratio of five participants-
per-item [48]. Exploratory factor analysis indicated a
single factor structure was likely therefore more than 100
participants were required. The internal consistency was
determined from Cronbach’s α coefficient as calculated at
an anticipated value range of 0.80-0.95 [49]. A student
T-test was developed to check that items behaved the
same way for males and females.
The sensitivity or measurement error score was deter-
mined from the MDC90 analysis that was performed as
described by Stratford [50]. The standard error of the
measurement (SEM) was calculated using the formula:
SEM = s√(1–r), where s = standard deviation of the test
scores (SD) of time 1 and time 2, r = the reliability coeffi-
cient for the test and Pearson’s correlation coefficient
between test and retest values [51]. To investigate statis-
tical agreement between the test scores of Time 1 and time
2 a Bland-Altman test was also performed (Figure 2).
Thereafter the MDC90was calculated using the formula:
MDC90 ¼ SEM √2 1:65:
Criterion validity was determined through the concur-
rent use of the WOMAC for specific criterion validity
with the LLFI-Sp measure and with the EQ-5D-3 L total
score and EQ-5D-3 L-VAS scores for criterion validity with
general health status. The Pearson’s r correlation coeffi-
cient used the criteria of poor (r < 0.49), fair (r = 0.50-0.74)
and strong (r > 0.75) [52].
The minimum sample sizes for the validation study
were calculated from the original study where respect-
ively criterion validity was determined through use of
Meng’s test of significance and solving for n [53] and
reliability was determined from an 80% likelihood of
detecting differences between the baseline and repeated
measurements. Both calculations allowed for a 15% attri-
tion with p < 0.05 [44]. Power calculations indicated the
need for a minimum sample of n ≥ 110 for concurrent
criterion validity and n ≥ 45 for reliability [52].
Figure 2 Blant-Altman plot for the test-retest reliability.
Figure 3 Scree plot of the exploratory one-factor solution.
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istical Package for Social Science version 17.0 (SPSS 17.0)
for Windows and LISREL 8.80 [54].
Results
The demographic and frequency of diagnosis of the sam-
ple are detailed in Table 1. The LLFI was translated and
back translated with consideration of the Spanish cul-
tural linguistic adaptation to provide the new LLFI-Sp
questionnaire without language difficulties or other con-
ceptual misunderstanding (Additional file 1). The mean
and standard deviation for LLFI-Sp score were determined
(5.88 ± 5.6 points), there were no missing responses and a
high degree of internal consistency (α = 0.91) was demon-
strated with an item range of 0.88 to 0.95.
The test-retest reliability was high at (ICC = 0.96) with
a range of 0.93 to 0.97. Measurement error from SEM
and MDC90 were respectively 3.12% and 7.12%. No sig-
nificance gender differences were found in the item re-
sponses. The Bland-Altman plot showed a high level of
agreement between the test scores at Time 1 and 2
(Figure 2).
For factor analysis the correlation matrix for the LLFI-Sp
was determined as suitable from the Kaiser-Meyer-Oklin
values (0.86) and Barlett’s Test of Sphericity (p < 0.001).
This indicated that the correlation matrix was unlikely to
be an identity matrix and was therefore suitable for MLE.
The a-priori requirements for one-dimensional factor
structure were verified. The screeplot (see Figure 3) indi-
cated a one-factor solution when all three a-priori fac-
tors were accounted for. The factor analysis revealed asatisfactory percentage of total variance explained by the
one factor at 22.8%. It was noted that eight factors had
Eigenvalues >1.0 and accounted for 65.4% of variance;
however those with an Eigenvalue >1.0 each accounted
for <10% of variance and were shown to be after the scree-
plot initial inflection point (Figure 3) and consequently not
extracted. The item loading for the one-factor solution for
the MLE method and average score for each item is shown
in Table 2.
Criterion validity determined from the relationship be-
tween the LLFI-Sp and WOMAC was strong (r = 0.77)
but fair and inversely related for the LLFI-Sp and the
EQ-5D-3 L (r = −0.62) and EQ-5D-3 L-VAS (r = −0.58).
Table 2 Factor loading items for the one-factor solution, average score and discrimination indices of items (n = 136)
Question Item Factor loading Item average score Item discr. indices
1 Stay at home most of time .780 .25 .259*
2 Change positions frequently .703 .38 .811**
3 Avoid heavy jobs .466 .75 .561**
4 Rest more often .691 .75 .388*
5 Get others to do things .726 .38 .656**
6 Pain almost all the time .690 .38 .822**
7 Lifting and carrying .735 .75 .561*
8 Appetite affected .740 .13 .334*
9 Walking/normal recreation/sport .796 .75 .561**
10 Home/family duties and chores .514 .38 .665**
11 Sleep less well .607 .38 .622**
12 Assistance with personal care, hygiene .706 .13 .690**
13 Regular daily activity work/social .601 .63 .811**
14 More irritable/bad tempered .497 .13 .776**
15 Feel weaker or stiffer .838 .25 .622**
16 Transport independence .687 .13 .863**
17 Difficulty or need with dressing (e.g. trousers/pants/shoes and socks) .849 .25 .480*
18 Difficulty changing directions, twisting or turning. .429 .25 .509*
19 Unable to move as fast as I would wish. .664 .50 .209*
20 I have difficulty with prolonged or extended standing. .658 .50 .863**
21 Difficulty bending, squatting and/or reaching down. .645 .63 .767**
22 Difficulty with long or extended walks. .249 .63 .523*
23 Difficulty with steps and stairs. .471 .88 .624**
24 Difficulty with sitting for prolonged or extended times. .620 .25 .782**
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Main findings
The LLFI was translated to provide a cross-cultural
adaptation to the Spanish language. The translation
process ensured the conceptual equivalence of the used
terms. This provided accessibility to the LLFI for the
second largest geographically used language. The psy-
chometric properties, specifically construct and criterion
validity, reliability and internal consistency were deter-
mined and found to be strong and the single factor
structure indicated a single summated score could be
used [36].
The cross-cultural adaptation of the LLFI into Spanish
enables clinicians in Spanish speaking settings to compare
outcomes following their treatments and interventions
affecting the lower limb. The procedure of cross-cultural
adaptation of a scale has been used in previous studies
for different scales to be applied in the Spanish context
[43,44]. It is critical to employ research measures that arevalid and reliable but they must also be both culturally and
linguistically appropriate [41].
The one-factor solution that emerged in the factor
analysis accounted for a significant proportion of vari-
ance. Though this value is lower than the 30.3% found
in the original study it is still an acceptable level for a
25-item questionnaire [52]. This evidence also supports
the presence of construct validity. A one-factor solution
is critical if a PRO is to be used with a single summated
score [36], and subsequently reflect the construct for
which it is primary used [6] – that of representation of
the functional status of the lower limb as a single kinetic
chain [7].
Four further critical psychometric properties of the
LLFI-Sp were shown to be well supported. The internal
consistency analysis at α = 0.91 was identical to that
of the original English version [7], which sits below
the accepted 0.95 thresholds for item redundancy [36].
The test-retest reliability or reproducibility (r = 0.96 and
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(0.97) [7]. The criterion validity with the WOMAC was
demonstrated as strong (r = 0.77) suggesting transferability
and substitution may be an option. This is supported by
the remaining psychometric factors that are preferable and
that the LLFI was designed as a lower limb regional tool
rather than a joint or condition specific measure, as was
the case for the WOMAC. The EQ-5D-3 L was fair and in-
versely correlated (r = −0.62) but at a lower level suggesting
substitution for general health measurement and vice versa
is unlikely to be appropriate. The directional trend how-
ever supports the construct validity and the determination
of the LLFI-Sp as appropriate in terms of face and content
validity as a deteriorating health correlates to worsening
function. The level of measurement error with an MDC90
of 7.12% was comparable that larger than that of the ori-
ginal LLFI at 6.6%.
Study strengths and limitations
The strengths of the study include the prospective nature
and the adequate number of subjects that provided a
suitable sample size and power of analysis. The inclusion
of consecutive patients, independence of the assessors
and referral source as well as the broad diagnosis and
category representations suggests limited selection bias
and the potential for population generalizability [48].
The results for the psychometric properties support the
findings of the previous research on the original English
version of the LLFI indicating broad cross-cultural adap-
tions would be appropriate to other diverse socioeco-
nomic, cultural and linguistic groups. The LLFI-Sp also
provides a means of comparing lower limb health status
in Spanish-speaking patients with their English-speaking
counterparts in countries with a high Spanish-speaking
population such as the United States.
The study limitations include the lack of longitudinal
data regarding other psychometric properties, including
responsiveness or sensitivity to change, and a minimal
clinically important difference. Also face and content
validity which should also be performed in a translated
instrument were not determined within a patient focus
subgroup but from the transilational aspects only. The
translation process ensured the conceptual equivalence
of the used terms, however only the translators and no
with cognitive interviews tested this before validation.
The determination of construct validity through the use
of factor analysis represents only one possible statistical
method of testing this property. A construct is not re-
stricted to one set of observable indicators or attributes
and additional indicators will require consideration in
future research. Similarly, the practical characteristics
were not determined. The results are applicable only to
the Spanish speaking population from Spain. The inclu-
sion of Hispanic/Latino/South American participants infuture studies could potentially provide confirming or
conflicting linguistic information due to the cultural and
ethnic difference with respect to the Spanish participants
and their cultural diversity in terms of European versus
the Americas, North, Central and South.
Conclusions
The LLFI is translated and cross-culturally adapted to
Spanish for the first time. The psychometric properties
of this LLFI Spanish version are also reported with the
determined values found to be satisfactory and support-
ive of the findings of the LLFI scale in the English format,
particularly in the areas of internal consistency, reliabil-
ity, factor structure and error score. Consequently the
LLFI-Sp may be useful in Spanish-speaking populations
and for making cross-ethnic and cross-cultural compari-
sons in other English speaking countries with a high
Spanish-speaking population.
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